Editor's Page: The Journal, Joseph B. Schwartz
Letters to the Editor
PDA's Commentary: Current Good Manufacturing Practice; Proposed Revision of Certain Requirements for Finished Pharmaceuticals; Proposed Rule, May 3, 1996; PDA
Use of the Green Fluorescent Protein to rapidly assess viability of E. coli in preserved solutions; Warren M. Casey, Ngoc-Anh T. Nguyen
Parenteral Formulation of Flavopiridol (NSC-649890); Rose-Marie Dannenfelser, Yosyong Surakitbanharn, S. Esmail Tabibi, and Samuel H. Yalkowsky
Enhancing Effect of Non-ionic Surfactant on the Inactivation of Lipopolysaccharide by Steam-Heat Treatment I; Takaaki Bamba, Rakan Matsui, and Kazuo Watabe
Stabilization of Teniposide in Aqueous Mixtures of Detergent-Phospholipid; Kyonghee Son and Hayat Alkan-Onyuksel
Antibody Mediated Lung Targeting of Long Circulating Emulsions; Young K. Song, Dexi Liu, Kazuo Maruyama, and Tomoko Takizawa
Current Approaches in Leak Testing Pharmaceutical Packages; Dana Morton Guazzo
The FDA-483: History and Use in Drug Inspections; Dale Cooper
Microbial Barrier Assessment of Tyvek Stopper Packaging for Rubber Closures; Jeanne E. Moldenhauer, Sheila A. Bass, Michael J. Kupinski, Mary L. Walters, and Sandra L. Rubio
Analysis and Evaluation of Filter Cartridge Extractables for Validation in Pharmaceutical Downstream Processing; Oscar W. Reif, Peter Sölkner, and Jürgen Rupp
Reviewer Acknowledgment
Annual Author Index
Annual Title Keyword Index
Annual Contents Summary